Literature DB >> 10775079

Renal involvement in polyarteritis nodosa: evaluation of 26 Turkish children.

N Besbas1, S Ozen, U Saatci, R Topaloglu, K Tinaztepe, A Bakkaloglu.   

Abstract

Renal involvement is common in childhood polyarteritis nodosa (PAN). We report a retrospective analysis of the presentation and clinical course of 26 patients with PAN and renal involvement. The mean age was 9.3 years (range 1-14 years) and there were 12 boys and 14 girls. Renal symptoms at presentation were as follows: 3 had isolated proteinuria, 9 had nephritic syndrome, 2 had nephritic and nephrotic components, and 10 had renal failure with one of the above features. Two patients with isolated hypertension were diagnosed by angiography and classified as classical PAN. Patients either received prednisone p.o. alone (n=9), or prednisone plus cyclophosphamide p.o. (n=11), or pulse steroids with prednisone p.o. and cyclophosphamide (n=2); 4 did not receive any treatment. Patients who were given cyclophosphamide had a significantly better outcome than those who did not. We suggest that oral cyclophosphamide therapy and corticosteroids are effective in the treatment of PAN. The overall 1-year and 5-year survival rates of the patients were 72.5% and 60%, respectively. In conclusion, renal disease is a serious manifestation of PAN necessitating prompt and aggressive treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775079     DOI: 10.1007/s004670050769

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children.

Authors:  Feng Yu; Jian-Ping Huang; Wan-Zhong Zou; Ming-Hui Zhao
Journal:  Pediatr Nephrol       Date:  2006-02-21       Impact factor: 3.714

2.  Childhood Polyarteritis Nodosa: a prospective multicentre study from eastern India.

Authors:  Rakesh Mondal; Sumantra Sarkar; Priyankar Pal; Madhumita Nandi; Avijit Hazra; Tapas Kumar Sabui
Journal:  Indian J Pediatr       Date:  2013-10-10       Impact factor: 1.967

3.  Classic polyarteritis nodosa presenting rare clinical manifestations in a patient with hemophilia A.

Authors:  Tadashi Matsushita; Hiroaki Adachi; Hidetaka Watanabe; Yoshie Shimoyama; Tatsuya Adachi; Gen Sobue; Masafumi Ito; Tetsuhito Kojima; Hidehiko Saito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 4.  Problems in classifying vasculitis in children.

Authors:  Seza Ozen
Journal:  Pediatr Nephrol       Date:  2005-05-07       Impact factor: 3.714

5.  An unusual presentation of classic polyarteritis nodosa in a child.

Authors:  Rezan Topaloglu; Mediha Kazik; Isil Saatci; Mukaddes Kalyoncu; Barbaros E Cil; Nejat Akalan
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

6.  T cell Vbeta repertoires in childhood vasculitides.

Authors:  P A Brogan; V Shah; A Bagga; N Klein; M J Dillon
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

7.  Successful renal transplantation in a child with ANCA-associated microscopic polyangiitis.

Authors:  Nesrin Besbas; Fatih Ozaltin; Keriman Tinaztepe; Safak Güçer; Seza Ozen; Mehmet Bakkaloglu; Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2003-05-13       Impact factor: 3.714

Review 8.  Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood.

Authors:  Federica Vanoni; Alberto Bettinelli; Franco Keller; Mario G Bianchetti; Giacomo D Simonetti
Journal:  Pediatr Nephrol       Date:  2009-07-30       Impact factor: 3.714

9.  Polyarteritis nodosa with bilateral asynchronous testicular necrosis: a case report.

Authors:  Nicholas J Toepfer; Nektarios I Lountzis; Joseph C Ugoeke; Tammie C Ferringer
Journal:  Case Rep Urol       Date:  2011-07-31

10.  Childhood cutaneous vasculitis: a comprehensive appraisal.

Authors:  Aparna Palit; Arun C Inamadar
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.